SWN#NFMV&IF[BJY8E-.,-6K2[&A
SYSTEM PROCESSING...
SWN#NFMV&IF[BJY8E-.,-6K2[&A
SYSTEM PROCESSING...
Posted: 2025-04-24 04:43:16 UTC
This article contains some claims that are falsified. While not everything in the article is false, please proceed with extreme caution and verify any critical information independently.
This article contains some claims that are falsified. While not everything in the article is false, please proceed with extreme caution and verify any critical information independently.
Status
Last Updated
2025-04-24 04:43:51 UTC
Verified By
Rollup News
A new study investigates the impact of pre-treatment with oral P2Y12 inhibitors in patients with acute myocardial infarction (MI) and cardiogenic shock, with results published in EHJPharmacotherapy.
Evaluation of pre-treatment efficacy and safety in AMI-CS patients
Impact of oral P2Y12 inhibitors on acute MI and cardiogenic shock
Assessing the benefits of pre-treatment with P2Y12 inhibitors
Managing bleeding risks associated with pre-treatment